Sydenham chorea with difficulty to control: Case Report

Clozapine has proved to be an effective antipsychotic for the treatment of refractory schizophrenia – characterised by the persistence of symptoms despite optimal treatment trials with at least two different antipsychotics at adequate dose and duration – but its use is hampered by adverse effects. The development of clozapine-induced diabetes is commonly considered to arise as part of a metabolic syndrome, associated with weight gain, and thus evolves slowly. We present the case of an individual with refractory schizophrenia and metformin-controlled diabetes who developed rapid-onset insulin-dependent hyperglycaemia immediately after starting clozapine. Given the refractory nature of his illness, the decision was made to continue clozapine and manage the diabetes. This case supports the existence of a more direct mechanism by which clozapine alters glycaemic control, aside from the more routine slow development of a metabolic syndrome.

Download Full-text

Temsirolimus as Base Immunosuppressant for a Recipient With Metastatic Renal Cancer: Adequate Immunosuppression and Oncological Control—Case Report

Transplantation Proceedings ◽

10.1016/j.transproceed.2013.08.106 ◽

2014 ◽

Vol 46 (1) ◽

pp. 271-273 ◽

Cited By ~ 2

Author(s):

S.J. Chueh ◽

B.R. Sankari ◽

R. Gonzales-Chambers ◽

L. Lipscomb ◽

J. Africa ◽

...

Keyword(s):

Case Report ◽

Renal Cancer ◽

Control Case ◽

Metastatic Renal Cancer

Download Full-text

Acute pulpal-alveolar cellulitis syndrome V. Apical closure of immature teeth by infection control: Case report and a possible microbial-immunologic etiology

Oral Surgery Oral Medicine Oral Pathology ◽

10.1016/0030-4220(91)90285-k ◽

1991 ◽

Vol 71 (6) ◽

pp. 737-742 ◽

Cited By ~ 11

Author(s):

Robert J. Matusow

Keyword(s):

Case Report ◽

Infection Control ◽

Control Case ◽

Immature Teeth

Download Full-text

Evidence favoring the efficacy of convalescent plasma for COVID-19 therapy

10.1101/2020.07.29.20162917 ◽

2020 ◽

Cited By ~ 10

Author(s):

Stephen A. Klassen ◽

Jonathon W. Senefeld ◽

Patrick W. Johnson ◽

Rickey E. Carter ◽

Chad C. Wiggins ◽

...

Keyword(s):

Patient Outcome ◽

Clinical Trials ◽

Case Report ◽

Mortality Rate ◽

Therapeutic Agent ◽

Randomized Clinical Trials ◽

Matched Control ◽

Case Series ◽

Outcome Data ◽

Control Case

AbstractTo determine the effect of COVID-19 convalescent plasma on mortality, we aggregated patient outcome data from randomized clinical trials (RCT), matched-control, case series, and case report studies. Random-effects analyses of RCT data demonstrated that hospitalized COVID-19 patients transfused with convalescent plasma exhibited a lower mortality rate compared to patients receiving standard treatments. These data provide evidence favoring the efficacy of human convalescent plasma as a therapeutic agent in hospitalized COVID-19 patients.

Download Full-text